OPKO Health, Inc. Available-for-sale Securities, Amortized Cost Basis
OPKO Health, Inc. (OPK) had Available-for-sale Securities, Amortized Cost Basis of $2.05 million as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2017-11-08
- 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $2.05M.
- 2017-06-30: Available-for-sale Securities, Amortized Cost Basis $2.81M.
- 2017-03-31: Available-for-sale Securities, Amortized Cost Basis $3.41M.
- 2016-12-31: Available-for-sale Securities, Amortized Cost Basis $3.41M.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2017-09-30 | $2.05M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $2.81M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $3.41M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $3.41M 10-Q · filed 2017-11-08 | |
| 2016-09-30 | $4.19M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $8.08M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $8.08M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $2.98M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $15.40M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $15.40M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $12.90M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $10.04M 10-K · filed 2016-02-29 | $12.90M 10-K · filed 2015-02-27 |
| 2014-09-30 | $12.90M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $4.75M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $4.75M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $4.30M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $29.00M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $79.04M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $5.15M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $5.33M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $5.01M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $4.91M 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $1.49M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |